Nalbuphine hydrochloride injection

DRUG2 trials

Sponsors

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. Ltd

Conditions

Postoperative AnalgesiaRespiratory Insufficiency

Phase 2

The Evaluation of the Effectiveness and Safety of Nalbuphine Hydrochloride Injection for Analgesia in ICU Patients: A Multicenter, Randomized, Single-blinded, Parallel, Two-step Trial

RecruitingNCT06785571

Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyRespiratory Insufficiency

Start: 2023-08-30End: 2025-10-31Target: 204Updated: 2025-01-21

Phase 3

Evaluation of Safety and Efficacy of Nalbuphine Versus Morphine for Postoperative Analgesia

CompletedNCT06949852

Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. LtdPostoperative Analgesia

Start: 2024-08-07End: 2025-08-04Updated: 2026-06-25

Related Papers

Protocol for a multicenter, randomized, single-blind, non-inferiority trial comparing nalbuphine hydrochloride versus hydromorphone hydrochloride for analgesia in mechanically ventilated ICU patients

Frontiers in Pharmacology2026-04-28